+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report



Fractionated stereotactic radiosurgery and preservation of hearing in patients with vestibular schwannoma: a preliminary report



Neurosurgery 45(6): 1299-305; Discussion 1305-7



OBJECTIVE: Microsurgery and stereotactic radiosurgery (SRS) for vestibular schwannomas are associated with a relatively high incidence of sensorineural hearing loss. A prospective trial of fractionated SRS was undertaken in an attempt to preserve hearing and minimize incidental cranial nerve injury. METHODS: Thirty-three patients with vestibular schwannomas were treated with 2100 cGy in three fractions during a 24-hour period using conventional frame-based linear accelerator radiosurgery. The median tumor diameter was 20 mm (range, 7-42 mm). Baseline and follow-up evaluations included audiometry and contrast-enhanced magnetic resonance imaging. End points were tumor progression, preservation of serviceable hearing, and treatment-related complications. RESULTS: Thirty-one patients (32 tumors) were assessable for tumor progression and treatment-related complications and 21 patients for preservation of serviceable hearing, with a median follow-up interval of 2 years (range, 0.5-4.0 yr). Tumor regression or stabilization was documented in 30 patients (97%) and tumor progression in 1 (3%). The patient with tumor progression remains asymptomatic and has not required surgical intervention. Five patients (16%) developed trigeminal nerve injury at a median of 6 months (range, 4-12 mo) after SRS; two of these patients had preexisting trigeminal neuropathy. One patient (3%) developed facial nerve injury (House-Brackmann Class 3) 7 months after SRS. Preservation of useful hearing (Gardner-Robertson Class 1-2) was 77% at 2 years. All patients with pretreatment Gardner-Robertson Class 1 to 2 hearing maintained serviceable (Class 1-3) hearing as of their last follow-up examination. CONCLUSION: Three-fraction SRS with a conventional stereotactic frame is feasible and well tolerated in the treatment of acoustic neuroma. This study demonstrates a high rate of hearing preservation and few treatment-related complications among a relatively high-risk patient cohort (tumors > 15 mm or neurofibromatosis Type 2). Longer follow-up will be required to assess the durability of tumor control.

(PDF emailed within 1 workday: $29.90)

Accession: 010680581

Download citation: RISBibTeXText

PMID: 10598696


Related references

Impact of Cochlear Dose on Hearing Preservation following Stereotactic Radiosurgery and Fractionated Stereotactic Radiotherapy for the Treatment of Vestibular Schwannoma. Journal of Neurological Surgery. Part B, Skull Base 79(4): 335-342, 2018

Hearing Preservation in Stereotactic Radiosurgery for Vestibular Schwannoma. Journal of Neurological Surgery. Part B, Skull Base 80(2): 156-164, 2019

Hearing preservation in patients with unilateral vestibular schwannoma who undergo stereotactic radiosurgery: Reinterpretation of the auditory brainstem response. Cancer 118(21): 5441-5447, 2013

Preserved Cochlear CISS Signal is a Predictor for Hearing Preservation in Patients Treated for Vestibular Schwannoma With Stereotactic Radiosurgery. Otology and Neurotology 39(5): 628-631, 2018

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?. Journal of Neurosurgery 119 Suppl: 129-136, 2014

Hearing preservation in vestibular schwannoma stereotactic radiosurgery: what really matters?. Journal of Neurosurgery 109 Suppl: 129-136, 2009

Hearing preservation after gamma knife stereotactic radiosurgery of vestibular schwannoma. Cancer 104(3): 580-590, 2005

Hearing preservation after stereotactic radiosurgery for vestibular schwannoma: a systematic review. Journal of Clinical Neuroscience 16(6): 742-747, 2009

Stereotactic fractionated radiotherapy and LINAC radiosurgery in the treatment of vestibular schwannoma-report about both stereotactic methods from a single institution. International Journal of Radiation Oncology, Biology, Physics 80(5): 1485-1491, 2011

Fractionated vs. single-fraction stereotactic radiotherapy in patients with vestibular schwannoma : Hearing preservation and patients' self-reported outcome based on an established questionnaire. Strahlentherapie und Onkologie 193(3): 192-199, 2016

Stereotactic radiosurgery vs. fractionated radiotherapy for tumor control in vestibular schwannoma patients: a systematic review. Acta Neurochirurgica 159(6): 1013-1021, 2017

3D quantitative assessment of response to fractionated stereotactic radiotherapy and single-session stereotactic radiosurgery of vestibular schwannoma. European Radiology 26(3): 849-857, 2016

Early Radiosurgery Improves Hearing Preservation in Vestibular Schwannoma Patients With Normal Hearing at the Time of Diagnosis. International Journal of Radiation Oncology, Biology, Physics 95(2): 729-734, 2017

Radiosurgery and fractionated stereotactic radiotherapy of vestibular schwannoma. Hno 65(5): 434-442, 2017

Population-Based Study of Stereotactic Radiosurgery or Fractionated Stereotactic Radiation Therapy for Vestibular Schwannoma: Long-Term Outcomes and Toxicities. International Journal of Radiation Oncology, Biology, Physics 100(2): 443-451, 2017